20
Participants
Start Date
October 1, 2024
Primary Completion Date
September 30, 2025
Study Completion Date
September 30, 2026
Continuous glucose monitor
CGMs will be worn for a maximum of 10 days at 6-8 weeks postpartum.
Oral Glucose Tolerance Test
At 10-12 weeks postpartum, participants will complete an oral glucose tolerance test, which involves drinking a glucose substance and having glucose levels measured a maximum of 3 times.
Hemoglobin A1c
At 11-14 months postpartum, participants will be asked to have their blood drawn to check their hemoglobin A1c to look for signs of developed insulin resistance
RECRUITING
Ohio State University Medical Center, Columbus
Ohio State University
OTHER